X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/revances-botox-rival-gets-fda-approval-painful-neck-muscle-condition-2023-08-14/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761127
https://www.prnewswire.com/news-releases/brand-institute-partners-on-brand-name-and-nonproprietary-name-development-for-fda-approved-injection-for-frown-lines-301621569.html
https://health.economictimes.indiatimes.com/news/pharma/u-s-fda-approves-revances-botox-rival/94099904
https://endpts.com/following-crl-revance-says-its-clear-on-instructions-for-resubmitting-bla/
https://www.fiercepharma.com/pharma/abbvie-s-botox-patent-lawsuit-very-unlikely-to-derail-revance-s-rival-launch-analysts
https://www.fiercepharma.com/pharma/as-revance-nears-a-potential-launch-for-its-botox-competitor-abbvie-sues-to-stop-it
https://www.businesswire.com/news/home/20210222005783/en/Revance-Announces-Positive-Topline-Phase-2-Data-Supporting-Advancement-of-DaxibotulinumtoxinA-for-Injection-for-the-Treatment-of-Upper-Limb-Spasticity
https://www.businesswire.com/news/home/20191205005263/en/Revance-Announces-Publication-Pooled-Results-Phase-3/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://www.businesswire.com/news/home/20191125005249/en/Revance-Submits-Biologics-License-Application-BLA-FDA/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
Market Place
Share 
